NPPA notified regarding the computation of the retail price of Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v + Benzalkonium Chloride Solution 0.02% v/v (As preservative) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharma Laboratories Ltd. (Marketer)

Feb 05, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal">The National Pharmaceutical Pricing Authority (NPPA) on February 04, 2026, notified regarding the computation of the retail price of Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v + Benzalkonium Chloride Solution 0.02% v/v (As preservative) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharma Laboratories Ltd. (Marketer).

It states that the price of each ml containing:- Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v + Benzalkonium Chloride Solution 0.02% v/v (As preservative) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharma Laboratories Ltd. (Marketer) has been revised to Rs. 14.42/-.

 

[Notification no: 19(4975)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT